The importance of motion diagnostics to promote early physical activity in children with rheumatic diseases
Organizational Data
- DRKS-ID:
- DRKS00017272
- Recruitment Status:
- Recruiting ongoing
- Date of registration in DRKS:
- 2019-05-29
- Last update in DRKS:
- 2022-07-12
- Registration type:
- Retrospective
Acronym/abbreviation of the study
Beware
URL of the study
https://www.rheuma-kinderklinik.de/rheuma-zentrum/so-behandeln-wir/bewegungsanalyse/beware-projekt
Brief summary in lay language
Approximately 1,500 children and adolescents develop a juvenile type of rheumatism, the Juvenile Idiopathic Arthritis, in Germany each year. The inflammations in the joints affect everyday functionality, quality of life as well as physical activity. Despite significant improvements in drug treatment, around one-quarter of affected adolescents face long-term restrictions on everyday movements. It is believed that some of these long-term consequences can be avoided by appropriate movement support. However, there is uncertainty among physicians regarding the use of functional diagnostics to assess sports participation and the earliest possible use of active exercise therapy together with sport. As part of the project, special motion analysis will be used and an IT-based sports recommendation tool for children with rheumatism will be developed. In addition, the effect of this early sports recommendation is examined in comparison to the currently often practiced sports partial exemption. 125 children and adolescents with rheumatism will be medically assisted for up to two years and examined two to three times. In half of these children, the differentiated sports advice (sports advice tool) is used. The comparison group receives a standard care and recommendation for sport. Health status, motor performance and quality of life are compared. After successful completion of the study, pediatric rheumatologists and paediatricians in the German-speaking area should be provided with a counseling tool to advise all affected children and adolescents on the right and safe sports to prevent long-term restrictions.
Brief summary in scientific language
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and adolescents with predominant involvement of the joints and tendons. The disease often causes a circle of pain and inflammation, leading to functional restraints, muscular imbalances and restrictions in everyday movements as well as specific malpositions. In addition, this often results in an increase in physical and athletic inactivity with long-term deficits in motor abilities, which also persist after an inactive disease status. The patients bear a long-term increased risk of misuse and overloading of the musculoskeletal system, which increase distinctively, especially during sports, movements. In addition to the personal (psycho-social) perspective of the patients, a corresponding risk assessment of functional deficits is also of crucial importance in terms of health economics. Established children's rheumatism scores do not consider this, so that in addition to the clinical diagnostics movement diagnostics should be used. The results of the risk assessment of functional deficits can flow into an individual sports recommendation. There is an urgent need for research. The protocol of the planned prospective cohort and intervention study aims to evaluate criteria for the use of appropriate functional diagnostic methods with sports recommendation for JIA patients. Project results are indication criteria that lead to a more efficient use of resources in functional diagnostics, and a computer-based sports recommendation tool. Above all, the need-based care of patients with functional limitations should benefit. The goals are to improve the motor skills and quality of life of these patients. The study is conducted at the German Center for Pediatric and Adolescent Rheumatology (DZKJR). A mixed methods approach with randomized control group design for effects checking quantitative and qualitative data collections as well as an exploratory study design for the identification of functional deficits will be chosen. In addition, at the end of the study there will be a health economic evaluation of the costs and benefit parameters. About 125 newly diseased JIA patients with at least one actively affected joint will be recruited for 36 months and examined clinically as well as motion diagnostically on at two to three inpatient hospital stays. The established methods of three-dimensional (3D) motion analysis and the Deutsche Motorik Test (DMT) are used for differentiated motion diagnostics. Patients can be enrolled at two points in the study. At t0, newly diagnosed JIA-Patients with at least one affected joint aged 6-16 years can are included and will take part in three clinical visits t0, t1, t2 (stays are independent of the study). A change of protocol was made to also include pre-treated patients to enter the study at t1. Patients have to reach an inactive state of disease and fulfil the inclusion criteria of t0 in hindsight, as if they would have been at the clinic earlier (t0). From that point on (t1/t1’), this cohort (t1’) will fulfil the same study protocol as the patients included at t0. At t1/t1’, a stratified randomization into two intervention groups takes place with the onset of an inactive disease phase. This measurement will take place up to 14 months after t0 or at the point of inclusion for t1’-patients. Patients, who were included at t0, have to be checked for an inactive state of disease after max. 12 months. Then, they have an additional two months to come back to the clinic. This extension was made due to the Covid-19 pandemic. One of the intervention groups receives an individual sports recommendation based on the results of the movement diagnostics and the subjective self-assessment of the patient as well as the assessment of the therapist / tester (intervention a). There is a comparison to the group with a current standard sport recommendation (intervention b, general description of sport limitations). At the last measurement, the motor performance change will be checked within 3-9 months in both intervention groups. The duration of the intervention phase was extended from 3-6 to 3-9 months due to Covid-19. At this appointment, all patients receive individual sports advice (intervention a). In order to monitor the state of health and physical activity in the phases between hospital stays, patients take weekly/monthly surveys using TUM / DZKJR’s own WebApp. Since May 2020 an additional questionnaire is used to examine constraints regarding their physical activity during the intervention phase due to the Covid-19 pandemic. The primary endpoint of the study is to improve the function of JIA patients with a functional deficit through optimal sports recommendation. The secondary endpoint is a consistent minimal inflammatory activity and pain intensity as well as an improvement in health-related quality of life. At the end of the study, the sports recommendation tool will be adjusted on the basis of the study results and transferred to a software application.
Health condition or problem studied
- ICD10:
- M08.0 - Juvenile rheumatoid arthritis
- ICD10:
- M08.2 - Juvenile arthritis with systemic onset
- ICD10:
- M08.3 - Juvenile polyarthritis (seronegative)
- ICD10:
- M08.4 - Pauciarticular juvenile arthritis
- ICD10:
- M08.8 - Other juvenile arthritis
- Healthy volunteers:
- No Entry
Interventions, Observational Groups
- Arm 1:
- At the clinical visit t1/t1', the study group is divided into two groups with a stratified randomization. Arm 1 receives an individual sports advice and recommendation based on the results of the motion diagnostics and the subjective self-assessment of the patient as well as the assessment of the therapist / tester. Within 3-9 months, the changes in the motor performance will be checked in both intervention groups (t2).
- Arm 2:
- Arm 2 receives a standard sports recommendation at the clinical visit t1/t1'. Changes in the motor performance will be examined after 3-9 months. At the last clinical visit (t2) arm 2 receives an individual sports advice and recommendation as arm 1.
Endpoints
- Primary outcome:
- The primary endpoint in this study is the functional improvement of JIA patients with a functional deficit through an optimal sports recommendation. The parameters are collected at the measurement t1/t1' and t2. Changes are quantified with a fitness test (Deutscher Motorik-Test).
- Secondary outcome:
- The secondary endpoint is a consistent minimal inflammatory activity and pain intensity as well as an improvement in health-related quality of life. The parameters are recorded at t1/t1' and t2 in the clinic. For this purpose, clinical parameters and subjective parameters of a patient survey are used.
Study Design
- Purpose:
- Treatment
- Allocation:
- Randomized controlled study
- Control:
-
- Active control (effective treatment of control group)
- Phase:
- N/A
- Study type:
- Interventional
- Mechanism of allocation concealment:
- No Entry
- Blinding:
- Yes
- Assignment:
- Parallel
- Sequence generation:
- No Entry
- Who is blinded:
-
- Assessor
Recruitment
- Recruitment Status:
- Recruiting ongoing
- Reason if recruiting stopped or withdrawn:
- No Entry
Recruitment Locations
- Recruitment countries:
-
- Germany
- Number of study centers:
- Monocenter study
- Recruitment location(s):
-
- Medical center Deutsches Zentrum für Kinder- und Jugendrheumatologie Garmisch-Partenkirchen
Recruitment period and number of participants
- Planned study start date:
- 2019-05-06
- Actual study start date:
- 2019-05-06
- Planned study completion date:
- No Entry
- Actual Study Completion Date:
- No Entry
- Target Sample Size:
- 125
- Final Sample Size:
- No Entry
Inclusion Criteria
- Sex:
- All
- Minimum Age:
- 6 Years
- Maximum Age:
- 16 Years
- Additional Inclusion Criteria:
- T0: • Diagnosis of a JIA according to ILAR criteria (Petty et al., 2004) • new disease (shorter than 12 months) • Pre-treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and cortisone (maximum 0.2 mg / kg body weight prednisolone equivalent) is possible • Active JIA disease according to Wallace et al., 2004 • Age from 6 to 16 years • Involvement of the lower and / or upper limb and / or the spine • German Speaking T1': • Diagnosis of a JIA according to ILAR criteria (Petty et al., 2004), inactive state of disease (cJADAS 10: oligo ≤1.5, polyartikulär ≤2.5) • duration of disease at first visit to a pediatric rheumatoligist ≤ 12 months, 6-months intervals of rheumatological screenings after first diagnosis, total duration of disease ≤ 24 months at t1' • Pre-treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and cortisone (maximum 0.2 mg / kg body weight prednisolone equivalent) is possible • Age from 6 to 17years • Involvement of the lower and / or upper limb and / or the spine • German Speaking
Exclusion Criteria
T0: • Pre-treatment with Conventional Disease Modifying Anti-Rheumatic Drugs (cDMARDs) > 3 months and Biological Disease Modifying Anti-Rheumatic Drugs (bDMARDs) > 3 months • Chronic pain disorder • Neurological diseases • abnormalities of cognitive function • No interest • Pretreatment with cortisone> 0.2 mg / kg body weight prednisolone equivalent • Participation in other interventional studies T1': • Already participating at t0 • Pre-treatment with Conventional Disease Modifying Anti-Rheumatic Drugs (cDMARDs) > 15 months and Biological Disease Modifying Anti-Rheumatic Drugs (bDMARDs) > 15 months • intra-articular injection (<4 weeks ago) • Chronic pain disorder • Neurological diseases • abnormalities of cognitive function • No interest • Pretreatment with cortisone> 0.2 mg / kg • Participation in other interventional studies
Addresses
Primary Sponsor
- Address:
- Professur für Biomechanik im Sport, Fakultät für Sport- und Gesundheitswissenschaften, Technische Universität MünchenProf. Dr. Ansgar SchwirtzGeorg-Brauchle-Ring 60/6280992 MünchenGermany
- Telephone:
- 089 289 24580
- Fax:
- 089 289 24582
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- https://www.sg.tum.de/
- Investigator Sponsored/Initiated Trial (IST/IIT):
- Yes
Contact for Scientific Queries
- Address:
- Professur für Biomechanik im Sport, Fakultät für Sport- und Gesundheitswissenschaften, Technische Universität MünchenDr. Josephine GizikGeorg-Brauchle-Ring 60/6280992 MünchenGermany
- Telephone:
- 089 289 24648
- Fax:
- 089 289 24582
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- https://www.sg.tum.de/
Contact for Public Queries
- Address:
- Deutsches Zentrum für Kinder- und JugendrheumatologieMatthias HartmannGehfeldstr. 2482467 Garmisch-PartenkirchenGermany
- Telephone:
- 08821 701 1550
- Fax:
- 08821 701 9101
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.rheuma-kinderklinik.de
Principal Investigator
- Address:
- Professur für Biomechanik im Sport, Fakultät für Sport- und Gesundheitswissenschaften, Technische Universität MünchenDr. Josephine GizikGeorg-Brauchle-Ring 60/6280992 MünchenGermany
- Telephone:
- 089 289 24648
- Fax:
- 089 289 24582
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- https://www.sg.tum.de/
Sources of Monetary or Material Support
Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)
- Address:
- DLR Projektträger, Bereich Gesundheit, Abteilung Gesundheitswesen, VersorgungsforschungHeinrich-Konen-Straße 153227 BonnGermany
- Telephone:
- 0228-3821-1877
- Fax:
- 0228 3821-1257
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- https://www.dlr.de/pt
Ethics Committee
Address Ethics Committee
- Address:
- Ethikkommission der Fakultät für Medizin der Technischen Universität MünchenIsmaninger Str. 2281675 MünchenGermany
- Telephone:
- +49-89-41404371
- Fax:
- +49-89-41404199
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Vote of leading Ethics Committee
- Vote of leading Ethics Committee
- Date of ethics committee application:
- 2019-03-19
- Ethics committee number:
- 143/19 S
- Vote of the Ethics Committee:
- Approved
- Date of the vote:
- 2019-05-02
Further identification numbers
- Other primary registry ID:
- No Entry
- EudraCT Number:
- No Entry
IPD - Individual Participant Data
- Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
- No Entry
- IPD Sharing Plan:
- No Entry
Study protocol and other study documents
- Study protocols:
- No Entry
- Study abstract:
- No Entry
- Other study documents:
- No Entry
- Background literature:
- No Entry
- Related DRKS studies:
- No Entry
Publication of study results
- Planned publication:
- No Entry
- Publikationen/Studienergebnisse:
- No Entry
- Date of first publication of study results:
- No Entry
- DRKS entry published for the first time with results:
- No Entry
Basic reporting
- Basic Reporting / Results tables:
- No Entry
- Brief summary of results:
- No Entry